C. Korner et al., Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man : Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase, EMBO J, 18(23), 1999, pp. 6816-6822
Type IV of the carbohydrate deficient glycoprotein syndromes (CDGS) is char
acterized by microcephaly, severe epilepsy, minimal psychomotor development
and partial deficiency of sialic acids in serum glycoproteins. Here we sho
w that the molecular defect in the index patient is a missense mutation in
the gene encoding the mannosyltransferase that transfers mannose from dolic
hyl-phosphate mannose on to the lipid-linked oligosaccharide (LLO) intermed
iate Man(5)GlcNAc(2)-PP-dolichol, The defect results in the accumulation of
the LLO intermediate and, due to its leaky nature, a residual formation of
full-length LLOs. N-glycosylation is abnormal because of the transfer of t
runcated oligosaccharides in addition to that of full-length oligosaccharid
es and because of the incomplete utilization of N-glycosylation sites. The
mannosyltransferase is the structural and functional orthologue of the Sacc
haromyces cerevisiae ALG3 gene.